Fig. 3
From: Proteomic profiling of circulating plasma exosomes reveals novel biomarkers of Alzheimer’s disease
The measurements of exosomal proteins in dataset 2. C1QC (A), CO9 (B), CFAH (C), KVD30 (D), GP1BB (E), RSU1 (F), and A0A0G2JRQ6 (G) were increased in Alzheimer’s disease (AD) patients, and A2MG (H), ADA10 (I), A1AG2 (J), IGHA1 (K), and HV428 (L) were decreased in AD patients. AD, Alzheimer’s disease; FC, fold change. C1QC, complement C1q subcomponent subunit C; CO9, complement component C9; CFAH, complement factor H; KVD30, immunoglobulin kappa variable 2D-30; GP1BB, platelet glycoprotein Ib beta chain; RSU1, Ras suppressor protein 1; A0A0G2JRQ6, Ig-like domain-containing protein; A2MG, alpha-2-macroglobulin; ADA10, disintegrin and metalloproteinase domain 10 (ADAM10); A1AG2, alpha-1-acid glycoprotein 2; IGHA1, immunoglobulin heavy constant alpha 1; HV428, immunoglobulin heavy variable 4-28